News
Early proof points confirm transformation strategy traction LOUISVILLE, Colo., May 14, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings ...
Trial will evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy in both plexiform neurofibromas and cutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback